Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
125.80    0.60 (0.48%)
Bid:
124.00
Ask:
126.20
Spread: 2.20 (1.774%)
Market Cap: £391.70m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

Director/PDMR Shareholding

13 Mar 2015 15:56

RNS Number : 4479H
Michael Page International PLC
13 March 2015
 



 

 

Michael Page International plc (the "Company")

 

 

Notification of Interests of Directors and Persons Discharging Managerial Responsibility ("PDMRs")

 

Vesting of Shares Under The Michael Page International plc Annual Bonus Plan 2004

 

On 12 March 2015 UBS Trustees (Jersey) Limited, the trustee of the Michael Page Employees' Benefit Trust ("EBT") transferred the legal title to the number of Ordinary shares of 1p in the Company (the "Shares") as set out in the table below to Steve Ingham, CEO of the Company, for nil cost, as a result of the vesting of his allocation under The Michael Page International plc Annual Bonus Plan. Of these, the trustee of the EBT arranged for the sale of sufficient of such Shares on behalf of Mr Ingham in order to reimburse the Company for his personal tax and national insurance contributions arising. The number of Shares sold and transferred was as follows:-

 

Name of Director

Total No of Shares Transferred on 12 March 2015

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

No of Shares Retained

Steve Ingham

8,631

4,085

£5.04397

4,546

 

 

Vesting of Shares Under The Michael Page International plc Incentive Share Plan 2004

 

On 12 March 2015 UBS Trustees (Jersey) Limited, the trustee of the EBT transferred the legal title to the number of Ordinary shares of 1p in the Company (the "Shares") as set out in the table below, for nil cost, as a result of the vesting of their allocations under the deferred element of The Michael Page International plc Incentive Share Plan 2004.

 

The number of shares sold and transferred is as follows:-

 

Name of Director* or PDMR

Total No of Shares Transferred on 12 March 2015

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

No of Shares Retained

Steve Ingham*

82,011

38,817

£5.04397

43,917

Gary James

45,423

Nil

-

45,423

Fabrice Lacombe

41,929

41,929

£5.04397

Nil

Patrick Hollard

48,917

227

£5.04397

48,690

Oliver Watson

41,929

19,855

£5.04397

22,074

 

The performance element of the above awards lapsed.

 

Exercise of Options Under The Michael Page International plc Incentive Share Plan 2004

 

On 12 March 2015 the PDMR set out in the table below exercised his nil cost Deferred Option Award under The Michael Page International plc Incentive Share Plan 2004.

 

The number of shares sold and transferred is as follows:-

 

Name of PDMR

No of Deferred Options Exercised

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

Olivier Lemaitre

48,917

48,917

£5.00689

 

The Performance Option Award lapsed.

 

 

 

 

Exercise of Options under the Michael Page International plc Executive Share Option Scheme

 

On 11 March 2015 the undermentioned PDMRs exercised options as detailed in the table below under The Michael Page International plc Executive Share Option Scheme. The number of options exercised and shares sold were as follows:-

 

Name of PDMR

Total No of Options exercised

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

Fabrice Lacombe

350,000

350,000

£4.98484

Olivier Lemaitre

300,000

300,000

£5.00256

 

Sale of Ordinary Shares

 

On 11 March 2015 Annabel Watson, connected person to Oliver Watson, a PDMR, sold 80,000 Ordinary shares in the Company at a price of £5.00.

 

This announcement is made in accordance with DTR3.1.4 R(1).

 

 

 

Elaine Marriner - Company Secretary Tel 01932 264148

Ross Hawley - Director of Investor Relations Tel: 020 3077 8425

 

 

13 March 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFIFIDFISEID
Date   Source Headline
28th May 20261:22 pmRNSResult of AGM
7th May 20263:00 pmRNSBoard change
14th Apr 20267:00 amRNSFIRST QUARTER 2026 TRADING UPDATE
13th Apr 202610:51 amRNSAnnual Report & Accounts & Notice of AGM
10th Apr 202612:34 pmRNSNotice of First Quarter 2026 Trading Update
30th Mar 20261:51 pmRNSDirector/PDMR Shareholding
19th Mar 20269:18 amRNSHolding(s) in Company
17th Mar 20269:44 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
9th Mar 20269:21 amRNSHolding(s) in Company
5th Mar 20261:22 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSFull Year Results for the Year Ended 31 Dec 2025
4th Mar 202611:43 amRNSPageGroup plc - Board Changes
2nd Mar 20262:58 pmRNSNotice of 2025 Full Year Results
17th Feb 202612:50 pmRNSHolding(s) in Company
10th Feb 20263:55 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFOURTH QUARTER 2025 TRADING UPDATE
9th Jan 202610:23 amRNSNotice of Q4 and Full Year 2025 Trading Update
17th Dec 20252:17 pmRNSHolding(s) in Company
26th Nov 20259:38 amRNSHolding(s) in Company
24th Oct 202511:31 amRNSHolding(s) in Company
15th Oct 20257:00 amRNSTHIRD QUARTER 2025 TRADING UPDATE
13th Oct 202511:03 amRNSNotice of Third Quarter 2025 Trading Update
8th Oct 202511:31 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSHalf Year Results for the Period Ended 30 June 25
7th Aug 20259:58 amRNSNotice of 2025 Half Year Results
10th Jul 20257:00 amRNSSecond Quarter 2025 Trading Update
8th Jul 20255:03 pmRNSNotice of Second Quarter 2025 Trading Update
11th Jun 202511:45 amRNSPageGroup plc - Board Changes
9th Jun 20254:11 pmRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
4th Jun 202510:56 amRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSResult of AGM
9th Apr 20257:00 amRNSFirst Quarter 2025 Trading Update
24th Mar 20252:02 pmRNSDirector Declaration
19th Mar 20251:18 pmRNSHolding(s) in Company
18th Mar 20251:41 pmRNSDirector/PDMR Shareholding
18th Mar 20251:35 pmRNSDirector/PDMR Shareholding
14th Mar 20251:10 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFull Year Results for the Year Ended 31 Dec 2024
4th Mar 20259:40 amRNSNotice of 2024 Full Year Results
6th Feb 20259:44 amRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSFourth Quarter 2024 Trading Update
9th Jan 20254:25 pmRNSNotice of Q4 and Full Year 2024 Trading Update
31st Oct 20243:37 pmRNSNotification of Interests of Directors
14th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
10th Oct 202411:50 amRNSNotice of Third Quarter 2024 Trading Update
8th Aug 20247:00 amRNSHalf Year Results for the Period Ended 30 June 24

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.